During the past decade, Sandton Oncology Centre conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 13 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sandton Oncology Centre" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Pfizer" with 5 trials sponsored, "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sandton Oncology Centre" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Sandton Oncology Centre" are "Breast Cancer" (8 trials), "Melanoma" (3 trials), "Lymphoma" (2 trials), "Malignant Melanoma" (2 trials) and "Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Sandton Oncology Centre" in a lesser frequency.

Most popular intervention types in "Sandton Oncology Centre" are "Drug" (25 trials), "Biological" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Paclitaxel" (4 trials), "Abemaciclib" (2 trials), "Atezolizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sandton Oncology Centre" are 17 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sandton Oncology Centre". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Sandton Oncology Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sandton Oncology Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".